Results from the phase 2 trial of ridaforolimus, dalotuzumab, and exemestane compared to ridaforolimus and exemestane in advanced breast cancer Meeting Abstract
| Authors: | Rugo, H. S.; Tredan, O.; Ro, J.; Morales, S.; Musolino, A.; Afonso, N.; Ferreira, M.; Park, K. H.; Cortes, J.; Tan, A. R.; Blum, J. L.; Eaton, L.; Gause, C. K.; Wang, A.; Im, E.; Mauro, D. J.; Baselga, J. |
| Abstract Title: | Results from the phase 2 trial of ridaforolimus, dalotuzumab, and exemestane compared to ridaforolimus and exemestane in advanced breast cancer |
| Meeting Title: | 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 75 |
| Issue: | 9 Suppl. |
| Meeting Dates: | 2014 Dec 9-13 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2015-05-01 |
| Language: | English |
| ACCESSION: | WOS:000356730200165 |
| DOI: | 10.1158/1538-7445.sabcs14-pd5-1 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: PD5-1 -- 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium -- DEC 09-13, 2014 -- San Antonio, TX -- S -- Source: Wos |
